Your session is about to expire
← Back to Search
Hematopoietic Cell Transplantation for Sickle Cell Disease
Study Summary
This trial is studying pre-transplant immunosuppression and donor stem cell transplant to see if it can treat patients with severe blood diseases.
- Sickle Cell Disease
- Beta Thalassemia
- Sickle Cell-Beta Thalassemia
- Thalassemia
- Sickle Cell Thalassemia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2010 Phase 2 trial • 21 Patients • NCT00060424Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research allow for participation from geriatric individuals?
"This medical trial is enrolling individuals aged between 2 and 30 years old."
Is it possible for me to take part in this experiment?
"Qualified applicants for this research must have thalassemia and be between 2 and 30 years of age. Our team is seeking around 40 participants in total."
In what medical conditions is Hematopoietic Cell Transplantation commonly prescribed?
"Hematopoietic Cell Transplantation can be applied to combat various conditions like synovitis, ophthalmia, sympathetic disorders, and some types of lung cancer."
How many individuals are actively taking part in this research protocol?
"Affirmative. Clinicaltrials.gov contains data that suggests this research study is currently enrolling 40 participants from one site; the trial was first listed on December 29th 2020 and last edited November 3rd 2022."
Are there other research projects analyzing the effects of Hematopoietic Cell Transplantation?
"Currently, 1759 clinical trials exploring Hematopoietic Cell Transplantation are underway with 354 being Phase 3. Mishawaka Indiana is hosting several such studies while 51579 other sites around the world have ongoing research into this field."
Are there any openings left for participants in this research initiative?
"Clinicaltrials.gov confirms that this research initiative is presently recruiting, with the initial posting occurring on December 29th 2020 and a recent update made to it in November 3rd 2022."
Share this study with friends
Copy Link
Messenger